Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1917324-13-0

Post Buying Request

1917324-13-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (R)-2-((6-(3-((3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6- tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile

    Cas No: 1917324-13-0

  • No Data

  • No Data

  • No Data

  • Hangzhou Huarong Pharm Co., Ltd.
  • Contact Supplier
  • 2-[[6-[(3R)-3-[[3-[(2-Cyano-5-fluorophenyl)methyl]-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-4-pyrimidinyl]amino]-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitri

    Cas No: 1917324-13-0

  • No Data

  • No Data

  • No Data

  • SAGECHEM LIMITED
  • Contact Supplier
  • (R)-2-((6-(3-((3-(2-Cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile

    Cas No: 1917324-13-0

  • No Data

  • No Data

  • No Data

  • Shanghai Forever Synthesis Co.,Ltd.
  • Contact Supplier

1917324-13-0 Usage

Uses

(R)-2-((6-(3-((3-(2-Cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile is an impurity of Trelagliptin. Trelagliptin (Zafatek) is a pharmaceutical drug used for the treatment of type 2 diabetes.

Check Digit Verification of cas no

The CAS Registry Mumber 1917324-13-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,9,1,7,3,2 and 4 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1917324-13:
(9*1)+(8*9)+(7*1)+(6*7)+(5*3)+(4*2)+(3*4)+(2*1)+(1*3)=170
170 % 10 = 0
So 1917324-13-0 is a valid CAS Registry Number.

1917324-13-0Downstream Products

1917324-13-0Relevant articles and documents

Trelagliptin impurity and its composition

-

Paragraph 0021, (2016/11/17)

The invention discloses a trelagliptin impurity compound, an impurity compound-containing composition which is a trelagliptin bulk drug, and an application of the impurity compound for controlling mass of trelagliptin.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1917324-13-0